+++Thanks surius & pyrazole_4 articles request

[pendyala123]

1. Title: Ruxolitinib. Tyrosine-protein kinase JAK1/2 inhibitor, Treatment of myelofibrosis, Treatment of myeloproliferative neoplasms, Treatment of psoriasis.
Authors: Campas-Moya, C.
Journal: Drugs of the Future, 2010, 35(6): 457
link:

Код: Выделить всё

http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1509764&p_IsPs=N

No DOI available

2. Title: A potential role of ruxolitinib in leukemia
Authors: Kiran Naqvi, Srdan Verstovsek, Hagop Kantarjian, and Farhad Ravandi
Journal: Expert Opinion on Investigational Drugs, August 2011, Vol. 20, No. 8 : Pages 1159-1166

DOI:

http://dx.doi.org/10.1517/13543784.2011.589383

Код: Выделить всё

http://informahealthcare.com/doi/pdf/10.1517/13543784.2011.589383

3.title: Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs (pages 617–629)
Authors: Roy Fleischmann, Maurizio Cutolo, Mark C. Genovese, Eun Bong Lee, Keith S. Kanik, Seth Sadis, Carol A. Connell, David Gruben, Sriram Krishnaswami, Gene Wallenstein, Bethanie E. Wilkinson and Samuel H. Zwillich
Journal: Arthritis and rheumatism (2012), 64(3), 617-29

DOI:

http://dx.doi.org/10.1002/art.33383

Link:

Код: Выделить всё

http://onlinelibrary.wiley.com/doi/10.1002/art.33383/pdf

4. Title: JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Authors: Claire Harrison, D.M., Jean-Jacques Kiladjian, M.D., Ph.D., Haifa Kathrin Al-Ali, M.D., Heinz Gisslinger, M.D., Roger Waltzman, M.D., M.B.A., Viktoriya Stalbovskaya, Ph.D., Mari McQuitty, R.N., M.P.H., Deborah S. Hunter, Ph.D., Richard Levy, M.D., Laurent Knoops, M.D., Ph.D., Francisco Cervantes, M.D., Ph.D., Alessandro M. Vannucchi, M.D., Tiziano Barbui, M.D., and Giovanni Barosi, M.D.

Journal: New England Journal of Medicine 2012; 366:787-798

link:

Код: Выделить всё

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1110556

No DOI available

[pyrazole]

1

[surius]

2,3,4